Corinne Abate-Shen, PhD, and Alexandros Papachristodoulou, PhD, Molecular Pharmacology & Therapeutics: $272,484 over two years from the National Cancer Institute for "Investigating mitochondrial dysfunction in high-risk prostate cancer."